150 related articles for article (PubMed ID: 34160081)
1. Sclerotherapy Versus Cautery/Laser Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia.
Woodard TD; Yappel-Sinkko KB; Wang X; McCrae KR; Parambil JG
Laryngoscope; 2022 May; 132(5):920-925. PubMed ID: 34160081
[TBL] [Abstract][Full Text] [Related]
2. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
Hanks JE; Hunter D; Goding GS; Boyer HC
Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
[TBL] [Abstract][Full Text] [Related]
3. Office-based sclerotherapy for recurrent epistaxis due to hereditary hemorrhagic telangiectasia: a pilot study.
Boyer H; Fernandes P; Duran O; Hunter D; Goding G
Int Forum Allergy Rhinol; 2011; 1(4):319-23. PubMed ID: 22287439
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia.
Boyer H; Fernandes P; Le C; Yueh B
Int Forum Allergy Rhinol; 2015 May; 5(5):435-40. PubMed ID: 25643928
[TBL] [Abstract][Full Text] [Related]
5. Sclerotherapy for Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review.
Thiele B; Abdel-Aty Y; Marks L; Lal D; Marino M
Ann Otol Rhinol Laryngol; 2023 Jan; 132(1):82-90. PubMed ID: 35152768
[TBL] [Abstract][Full Text] [Related]
6. Septectomy and septal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia and septal perforation.
Lesnik GT; Ross DA; Henderson KJ; Joe JK; Leder SB; White RI
Am J Rhinol; 2007; 21(3):312-5. PubMed ID: 17621815
[TBL] [Abstract][Full Text] [Related]
7. Sclerotherapy and Topical Nasal Propranolol: An Effective and Safe Therapy for HHT-Epistaxis.
Esteban-Casado S; Martín de Rosales Cabrera AM; Usarralde Pérez A; Martínez Simón JJ; Zhan Zhou E; Marcos Salazar MS; Pérez Encinas M; Botella Cubells L
Laryngoscope; 2019 Oct; 129(10):2216-2223. PubMed ID: 30908653
[TBL] [Abstract][Full Text] [Related]
8. Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review.
Abiri A; Goshtasbi K; Maducdoc M; Sahyouni R; Wang MB; Kuan EC
Lasers Surg Med; 2020 Apr; 52(4):293-300. PubMed ID: 31441079
[TBL] [Abstract][Full Text] [Related]
9. The utility of bipolar electrocautery in hereditary hemorrhagic telangiectasia.
Ghaheri BA; Fong KJ; Hwang PH
Otolaryngol Head Neck Surg; 2006 Jun; 134(6):1006-9. PubMed ID: 16730547
[TBL] [Abstract][Full Text] [Related]
10. Laser photocoagulation in hereditary hemorrhagic telangiectasia.
Parkin JL; Dixon JA
Otolaryngol Head Neck Surg; 1981; 89(2):204-8. PubMed ID: 6787514
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial.
Peterson AM; Lee JJ; Kallogjeri D; Schneider JS; Chakinala MM; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1006-1014. PubMed ID: 32940653
[TBL] [Abstract][Full Text] [Related]
12. Sinonasal quality of life outcomes following laser treatment of epistaxis related to hereditary hemorrhagic telangiectasia.
Kuan EC; Peng KA; Thompson CF; Suh JD; Wang MB
Lasers Med Sci; 2017 Apr; 32(3):527-531. PubMed ID: 28116537
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the severity and progression of epistaxis in hereditary hemorrhagic telangiectasia 1 versus hereditary hemorrhagic telangiectasia 2.
Hunter BN; Timmins BH; McDonald J; Whitehead KJ; Ward PD; Wilson KF
Laryngoscope; 2016 Apr; 126(4):786-90. PubMed ID: 26372311
[TBL] [Abstract][Full Text] [Related]
14. In-Office KTP Laser for Treating Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis.
Wu V; Kell E; Faughnan ME; Lee JM
Laryngoscope; 2021 Mar; 131(3):E689-E693. PubMed ID: 32557619
[TBL] [Abstract][Full Text] [Related]
15. Randomized, controlled, double-blinded clinical trial of effect of bevacizumab injection in management of epistaxis in hereditary hemorrhagic telangiectasia patients undergoing surgical cauterization.
Khanwalkar AR; Rathor A; Read AK; Paknezhad H; Ma Y; Hwang PH
Int Forum Allergy Rhinol; 2022 Aug; 12(8):1034-1042. PubMed ID: 34989143
[TBL] [Abstract][Full Text] [Related]
16. The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
Harvey RJ; Kanagalingam J; Lund VJ
Am J Rhinol; 2008; 22(2):182-7. PubMed ID: 18416977
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy assessment of current treatment options for epistaxis in HHT.
Dür C; Anschuetz L; Negoias S; Bulut OC; Angelillo-Scherrer A; Caversaccio M
Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4321-4328. PubMed ID: 33661356
[TBL] [Abstract][Full Text] [Related]
18. Treatment of severe refractory epistaxis in hereditary hemorrhagic telangiectasia using a two-flap nasal closure method.
Timmins BH; Hunter BN; Wilson KF; Ward PD
Int Forum Allergy Rhinol; 2016 May; 6(5):544-8. PubMed ID: 26751606
[TBL] [Abstract][Full Text] [Related]
19. Comparison of electrosurgical plasma coagulation and potassium-titanyl-phosphate laser photocoagulation for treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
Luk L; Mace JC; Bhandarkar ND; Sautter NB
Int Forum Allergy Rhinol; 2014 Aug; 4(8):640-5. PubMed ID: 24719397
[TBL] [Abstract][Full Text] [Related]
20. Epistaxis in children and adolescents with hereditary hemorrhagic telangiectasia.
Gonzalez CD; Mcdonald J; Stevenson DA; Whitehead KJ; Petersen MG; Presson AP; Ding Q; Wilson KF
Laryngoscope; 2018 Jul; 128(7):1714-1719. PubMed ID: 29171658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
